A Study of the Views of Women Who Have Uterine Fibroids and About New Reproductive Technologies and Their Potential Uses

Overview

About this study

The purpose of this study is:

To assess how women who have undergone treatment for UF view the experience, whether they prioritize experimental approaches to remedy any impacts on their fertility, and the psychosocial and socio-economic factors most important to them in considering the preservation or restoration of fertility.
To assess the potential perceptions or experiences of women of African descent compared with women of other ethnic backgrounds of disparities in the symptoms and how treatment options for UF may impact willingness or ability to pursue approaches to fertility maintenance and restoration.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Between 18 and 45 years of age
Biologically female
English-speaking
US resident
Has received a diagnosis/treatment for symptomatic uterine fibroids

Exclusion Criteria:

Minor (under 18) or older than 45
Not biologically female
Non-English speaker
Not US resident
Has not received either a diagnosis or treatment for uterine fibroids

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Megan Allyse, Ph.D.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Megan Allyse, Ph.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials